METOZOLV ODT

Compare METOZOLV ODT  to:
Compare
Compare

Generic Name for METOZOLV ODT

Metoclopramide (as HCl) 5mg, 10mg; orally-disintegrating tabs; mint flavored.

Legal Classification:

Rx

Pharmacological Class for METOZOLV ODT

Antidopaminergic.

Manufacturer of METOZOLV ODT

Salix Pharmaceuticals, Inc.

Indications for METOZOLV ODT

To relieve symptoms associated with acute and recurrent diabetic gastroparesis.

Adult dose for METOZOLV ODT

Allow tablet to dissolve on tongue. 10mg 4 times daily 30 minutes before meals and at bedtime for 2–8 weeks. Renal impairment: reduce dose.

Children's dosing for METOZOLV ODT

Not recommended.

Contraindications for METOZOLV ODT

When stimulation of GI motility may be dangerous (eg, obstruction, perforation, or hemorrhage). Pheochromocytoma. Epilepsy. Concomitant drugs which may cause extrapyramidal reactions (eg, antidepressants, antipsychotics, neuroleptics).

Precautions for METOZOLV ODT

Discontinue if signs/symptoms of tardive dyskinesia develop; risk increases with duration of treatment and total cumulative dose. Parkinsonism. History of depression. Hypertension. CHF. Arrhythmia. Elderly. Pregnancy (Cat.B). Nursing mothers.

Interactions for METOZOLV ODT

Hypertensive crisis with MAOIs. Additive sedation with alcohol, other CNS depressants. Antagonized by anticholinergics and narcotics. Monitor insulin use; may diminish gastric and accelerate intestinal absorption of drugs or food.

Adverse Reactions for METOZOLV ODT

Headache, nausea, vomiting, fatigue, somnolence, dizziness, extrapyramidal effects, parkinsonism, tardive dyskinesia, neuroleptic malignant syndrome, hypertension.

How is METOZOLV ODT supplied?

Tabs—10 x 10 (blister packs)

Related Disease:

Nausea

Related Resources

Zentrip medicated strips available for motion sickness

January 29, 2010

Sato Pharmaceutical has made available over-the-counter Zentrip (meclizine HCl quick-dissolving strips) for the prevention and relief of nausea, vomiting, and dizziness associated with motion sickness.

Exel/Exelint infusion set needles recalled

January 26, 2010

FDA notified healthcare professionals of a Class I recall of Exel/Exelint Huber needles, Exel/Exelint Huber Infusion Sets, and Exel/Exelint "Securetouch+" Safety Huber Infusion Sets due to 'coring,' the cutting or dislodging of silicone cores or slivers from the ports into which they are inserted).

FDA warns of lead and arsenic in Nzu, a traditional morning sickness remedy

January 04, 2010

The FDA and the Texas Department of State Health Services have notified healthcare professionals and consumers, especially pregnant or nursing women, to avoid consuming a traditional morning sickness remedy called "Nzu," because of high levels of lead and arsenic found during laboratory analysis.

PrimaBella neuromodulation device available for treatment of morning sickness

December 08, 2009

Alaven's PrimaBella, a non-invasive prescription therapeutic device approved by the FDA for the treatment of nausea and vomiting due to pregnancy (NVP), has been made available.

Promethazine injection gains boxed warning

September 16, 2009

The FDA has notified healthcare professionals that a Boxed Warning is being added to the prescribing information for promethazine hydrochloride products, describing the risks of severe tissue injury, including gangrene, requiring amputation following intravenous administration of promethazine.